How AbbVie Inc. stacks up

ABBV · against 7 other Healthcare companies of similar size

Overall

53/ 100

Below the middle of the pack.

Ranked #5 of 8 · scores higher than 43% of peers

Bars: peers in each 10-point band of the overall score

2 peers with an overall score of 50–59, including ABBV · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#8 of 8Score 48 / 100 · beats 0%Growth#1 of 8Score 66 / 100 · beats 100%Profitability#4 of 8Score 87 / 100 · beats 57%Risk#8 of 8Higher relative risk · safety 9 · beats 0%

Ranking by overall score

Top 5 and the companies ranked around ABBV

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	AstraZeneca PLCAZN · US-listed	285.2B USD	63	66	64	86	1 / 2
1	Novartis AGNVS · US-listed	302.7B USD	63	68	57	94	2 / 2
3	Roche Holding AGRO.SW · Europe	317.9B CHF (≈$365.6B)	60	70	49	97	2 / 2
4	Johnson & JohnsonJNJ · US-listed	641.4B USD	59	58	48	91	1 / 2
5	AbbVie Inc.ABBV · US-listed	505.4B USD	53	48	66	87	2 / 2
6	Thermo Fisher Scientific Inc.TMO · US-listed	258.2B USD	47	53	44	71	2 / 2
6	UnitedHealth Group IncorporatedUNH · US-listed	363.0B USD	47	65	38	61	2 / 2
8	Merck & Co., Inc.MRK · US-listed	356.9B USD	37	54	20	55	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…